Description

QuilliChew ER is a medication used for the treatment of attention deficit hyperactivity disorder (ADHD). It is an extended-release formulation that allows for once-daily dosing, providing a steady release of the active ingredient throughout the day.

Interpreter Notes

Interpreters should be aware that QuilliChew ER may be referred to by its generic name, methylphenidate, in some contexts. It is important to maintain a formal register and avoid colloquial terms when discussing this medication. Ensure that patients understand the extended-release aspect, as it is crucial for adherence.

Example Sentences

EN: The doctor prescribed QuilliChew ER to help manage the patient's ADHD symptoms.

ES: El médico recetó QuilliChew ER para ayudar a controlar los síntomas de TDAH del paciente.

Common Interpreter Mistakes

Confusing QuilliChew ER with other methylphenidate formulations; misinterpreting the extended-release aspect; using informal language when discussing the medication.